CME: Mild to Moderate Acne in Primary Care: A Multidisciplinary Discussion

Mild to Moderate Acne in Primary Care: A Multidisciplinary Discussion

Mild to Moderate Acne in Primary Care: A Multidisciplinary Discussion
Whether it’s mild or severe, acne impacts patients’ quality of life in many ways. Here’s how to best manage this condition at the primary care level.

Available credits: 0.50

Time to complete: 30 minutes


Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    Particularly among adolescent patients, treating acne is a top concern, which is why primary care physicians need to dedicate time to have this discussion with their patients. To help you develop the best management plan, this activity will cover treatment options based on acne severity along with tips for improving patient adherence. 

  • Disclosure of Conflicts of Interest

    In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.


    Paul P. Doghramji, MD
    Family Physician
    Pottstown Memorial Medical Center
    Pottstown, PA

    Dr. Doghramji has nothing to disclose.


    Steven R. Feldman, MD, PhD
    Professor of Dermatology
    Wake Forest School of Medicine
    Winston-Salem, NC

    Dr. Feldman has disclosed he receives grant support from Abbvie, Celgene, Galderma Laboratories, L.P., Janssen, Lilly, Novartis Pharmaceuticals Corporation, Pfizer Inc., Regeneron, Sanofi, Taro; he participates in speaker bureaus for Abbvie, Celgene, Janssen, Leo Pharma Inc., Lilly, Novartis Pharmaceuticals Corporation, Ortho Dermatology, Pfizer Inc., Regeneron, Sanofi, Sun Pharma, Taro; he receives consulting fees from Abbvie, Advance Medical, Alvotech, Caremark, Celgene, Galderma Laboratories, L.P., Gerson Lehrman Group, Guidepoint Global, Janssen, Kikaku, Leo Pharma Inc., Lilly,, Merck & Co., Inc., Mylan, Novartis Pharmaceuticals Corporation, Ortho Dermatology, Pfizer Inc., Regeneron, Sanofi, Sienna, Sun Pharma, Suncare Research, Xenoport; and received royalties from Causa Technologies (Founder, CTO), Informa, Medical Quality Enhancement Corporation (Majority Owner), UpToDate, Xlibris.

    Reviewers/Content Planners/Authors:

    • Ken Brown has nothing to disclose.
    • Carole Drexel, PhD, CHCP has nothing to disclose.
    • Ann Early has nothing to disclose.
    • Ashley Rosenthal has nothing to disclose.
  • Learning Objectives

    After participating in this educational activity, participants should be better able to:

    • Describe the physical and psychosocial impacts of acne and associated scarring on affected patients in addition to the importance of early treatment.
    • Recommend a comprehensive, evidence-based treatment regimen that includes the appropriate use of over-the-counter treatment options for patients with mild to moderate acne.
    • Employ a shared decision-making approach to the management of acne, educating patients on treatment expectations and accounting for patient preference and access to prescription medicines.
  • Target Audience

    This activity is designed to meet the educational needs of primary care physician, family medicine physicians, nurse practitioners and physician assistants, pediatricians, obstetricians, gynecologists, and pharmacists.

  • Accreditation and Credit Designation Statements

    The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • Provider

    Prova Education, designs and executes continuing education founded on evidence-based medicine, clinical need, gap analysis, learner feedback, and more. Our mission is to serve as an inventive and relevant resource for clinical content and educational interventions across a broad spectrum of specialties. 
    Prova Education's methodology demonstrates a commitment to continuing medical education and the innovative assessment of its effects. Our goal is clear—to develop and deliver the very best education in the most impactful manner and to verify its results with progressive outcomes research.  

  • Commercial Support

    This activity is supported by an independent educational grant from Galderma USA.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of TOPEC and Prova Education. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of Prova Education you are subject to the terms and conditions of use, including copyright and licensing restriction, of that site.

    Reproduction Prohibited

    Reproduction of this material is not permitted without written permission from the copyright owner.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience.

Facebook Comments

Sign up for the Prova Education newsletters.

Better education for a better you.

* Required

We’re glad to see you’re enjoying Prova Education…
but how about a more personalized experience?

Register for free